{"url_path":"/sec/cue/8-k/2026-06-03/item-5-02","section_key":"item-5-02","section_title":"Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-03","source_url":"https://www.sec.gov/Archives/edgar/data/1645460/0001193125-26-255479-index.html","accession_number":"0001193125-26-255479","cik":"0001645460","ticker":"CUE","issuer_name":"Cue Biopharma, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1645460/0001193125-26-255479-index.html","primary_entity_key":"0001645460","primary_entity_name":"Cue Biopharma, Inc."},"word_count":125,"has_tables":true,"body_markdown":"Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers\n\n \n\nAt the Special Meeting of Stockholders of Cue Biopharma, Inc. (the “Company”) held on June 1, 2026 (the “Special Meeting”), the Company’s stockholders approved the Cue Biopharma, Inc. 2026 Stock Incentive Plan (the “2026 Plan”), which had previously been adopted by the Board, subject to stockholder approval.\n\n \n\nThe description of the 2026 Plan contained on pages 16-31 of the Company’s definitive proxy statement for the Special Meeting, filed with the Securities and Exchange Commission on May 21, 2026 (the “Proxy Statement”), is incorporated herein by reference. A complete copy of the 2026 Plan is attached hereto as Exhibit 10.1 and is incorporated herein by reference."}